All News
Filter News
Found 6,650 articles
-
Entellus Medical Receives FDA 510(k) Clearance for FinESS(TM) Endoscope
2/24/2011
-
Pharming Group and Santarus Inc. Announce Initiation of Phase IIIb Clinical Study with RHUCIN in Acute Hereditary Angioedema
2/22/2011
-
Biomarker Could Make Diagnosing Knee Injury Easier, Less Costly, Stanford University Medical Center Othopaedists Say
2/17/2011
-
Alkermes Announces Positive Preliminary Results from Phase 2 Study of ALKS 37 for Treatment of Opioid-Induced Bowel Dysfunction
2/15/2011
-
Teva Pharmaceutical Industries Limited Announces Results from a Phase III Study for QNAZE(TM) Nasal Aerosol in Perennial Allergic Rhinitis; All Endpoints Met
2/9/2011
-
BioElectronics Corporation Retains Scarsdale Equities LLC to Explore Strategic Alternatives
2/3/2011
-
Massachusetts Court Rules in Favor of Volcano Corporation and Against St. Jude Medical Subsidiary in Trade Secrets Case
2/1/2011
-
OXIS International, Inc.'s Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week
1/31/2011
-
Ascenion GmbH Release: Non-hallucinogenic LSD Derivative for Treating Cluster Headache, Has Acquired an Equity Stake in Entheogen Corporation
1/31/2011
-
Newly Published Data in Pain Practice Demonstrates Cumberland Pharmaceuticals'S Caldolor(R) Significantly Reduces Pain and Morphine Use in Post-Operative Patients
1/27/2011
-
Alzheimer's Drug Discovery Foundation Funds ALS Biopharma LLC to Develop Small Molecules for Alzheimer's Disease
1/27/2011
-
Sanofi-Aventis (France)'s Allergy Treatment Drug Allegra Gets FDA Approval For OTC Use
1/26/2011
-
Amarillo Biosciences and Oasis Sign License and Supply Agreement for Dietary Supplement Maxisal(R)
1/14/2011
-
Orexo AB Announces FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
1/10/2011
-
NuPathe Inc. Announces FDA Acceptance of Zelrix NDA for Filing
1/10/2011
-
Allozyne, Inc. Announces Completion of Phase Ia Trial By Az01, a Long Lasting Interferon ? for Treatment of Relapsing Remitting Multiple Sclerosis
1/10/2011
-
Stellar Pharmaceuticals Inc. Annouces the Approval of Uracyst(R) by the KFDA in South Korea
1/6/2011
-
Carbylan BioSurgery, Inc. Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued
1/5/2011
-
Pharming Group and Swedish Orphan Biovitrum Announce First Sales of Ruconest in Europe
12/28/2010
-
Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
12/27/2010